Active — Not RecruitingNot Applicable

Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study

United States204 participantsStarted 2018-10-12

Plain-language summary

This study evaluates the effect of bladder cancer treatment on quality of life.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Have pathologically confirmed, clinically localized, bladder cancer * Be willing to complete a survey in English before starting definitive treatment (surgery or radiation); * Able to give consent. Exclusion Criteria: * Does not meet inclusion criteria

What they're measuring

Change in quality of life outcomes - PROMIS-29

Timeframe: At baseline, 6, 12, 24, and 36 months

Change in quality of life outcomes - Bladder Cancer Index

Timeframe: At baseline, 6, 12, 24, and 36 months

Patient level characteristics

Timeframe: At baseline, 6, 12, 24, and 36 months after treatment

Trial details

NCT IDNCT06350734

SponsorMayo Clinic

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2029-01-31

View on ClinicalTrials.gov More Stage 0a Bladder Cancer AJCC v8 trials